Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

5 results
Display

A case of prostate cancer in 34 year old man presenting with generalized lymphadenopathy mimicking malignant lymphoma

Ahn MJ, Oh SJ, Lee YY, Jung TJ, Kim IS, Choi IY, Jang SJ, Park YW, Shin KY, Kim YS

We report a case of prostate cancer in 34 year old man presenting with generalized lymphadenopathy mimicking malignant lymphoma without any urinary symptoms. Lymph node biopsy revealed metastatic adenocarcinoma...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Establishment of Reference Intervals of Tumor Markers in Korean Adults

Woo HY, Kim YJ, Park H

BACKGROUND: The sensitivity and specificity of tumor markers for detecting cancer could be significantly changed by the reference intervals of tumor markers. We established reference intervals of tumor markers in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Significance of intraprostatic architecture and regrowth velocity for considering discontinuation of dutasteride after combination therapy with an alpha blocker: A prospective, pilot study

Shindo T, Hashimoto , Shimizu T, Itoh N, Masumori N

PURPOSE: We conducted a prospective single-center study to evaluate the possibility of discontinuation of dutasteride after combination therapy with an alpha blocker for benign prostatic hyperplasia (BPH). MATERIALS AND METHODS: We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cancer of the Prostate Risk Assessment (CAPRA) Preoperative Score Versus Postoperative Score (CAPRA-S): Ability to Predict Cancer Progression and Decision-Making Regarding Adjuvant Therapy after Radical Prostatectomy

Seo WI, Kang PM, Kang DI, Yoon JH, Kim W, Chung JI

The University of California, San Francisco, announced in 2011 Cancer of the Prostate Risk Assessment Postsurgical (CAPRA-S) score which included pathologic data, but there were no results for comparing preoperative...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Elderly men over 65 years of age with late-onset hypogonadism benefit as much from testosterone treatment as do younger men

Saad F, Yassin A, Haider A, Doros G, Gooren L

PURPOSE: To investigate the potential benefits of testosterone administration to elderly men (>65 years) with late-onset hypogonadism (LOH) in comparison with younger men and to assess the safety of testosterone...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr